Actually your post here has made me think about some the up coming catalysts that AHZ has in the pipe line.
- Extending the use of CardioCel® for an expanded range of indications in cardiovascular surgery;
- Expanding regenerative tissue portfolio and explore the use of ADAPT® prepared tissue for additional surgical applications that have the potential to increase revenue in the future;
- Initial Asian market approval for CardioCel®;
- Initiation of HSV-2 Phase II examine the safety of the vaccine in people infected with the virus as well as the immune response in these people.; and
- Initiation of HPV Phase I
AHZ may be a lot closer to announcing this achievement than we think.
- Forums
- ASX - By Stock
- Ann: Admedus to showcase CardioCel at EACTS Annual Meeting
Actually your post here has made me think about some the up...
-
- There are more pages in this discussion • 61 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$14.30 |
Change
0.050(0.35%) |
Mkt cap ! $303.7M |
Open | High | Low | Value | Volume |
$14.20 | $14.76 | $13.70 | $104.3K | 7.33K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 895 | $14.25 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.59 | 415 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 794 | 14.410 |
1 | 200 | 14.400 |
1 | 415 | 14.350 |
1 | 895 | 14.250 |
1 | 489 | 14.150 |
Price($) | Vol. | No. |
---|---|---|
14.770 | 574 | 3 |
15.000 | 421 | 1 |
15.140 | 160 | 1 |
15.150 | 149 | 1 |
15.500 | 44 | 1 |
Last trade - 10.52am 12/08/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |